These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9691189)

  • 1. Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum.
    Poeggeler B; Rassoulpour A; Guidetti P; Wu HQ; Schwarcz R
    Dev Neurosci; 1998; 20(2-3):146-53. PubMed ID: 9691189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.
    Poeggeler B; Rassoulpour A; Wu HQ; Guidetti P; Roberts RC; Schwarcz R
    Neuroscience; 2007 Aug; 148(1):188-97. PubMed ID: 17629627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum.
    Roceri M; Molteni R; Fumagalli F; Racagni G; Gennarelli M; Corsini G; Maggio R; Riva M
    J Neurochem; 2001 Feb; 76(4):990-7. PubMed ID: 11181818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct and interactive effects of d-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat.
    Zahm DS; Williams ES; Krause JE; Welch MA; Grosu DS
    J Comp Neurol; 1998 Nov; 400(4):487-503. PubMed ID: 9786410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation and function of kynurenic acid in the immature rat brain.
    Schwarcz R; Ceresoli-Borroni G; Wu HQ; Rassoulpour A; Poeggeler B; Hodgkins PS; Guidetti P
    Adv Exp Med Biol; 1999; 467():113-23. PubMed ID: 10721048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
    Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
    J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
    Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA
    J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum.
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2002 Mar; 109(3):239-49. PubMed ID: 11956948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.
    Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
    Amori L; Wu HQ; Marinozzi M; Pellicciari R; Guidetti P; Schwarcz R
    Neuroscience; 2009 Mar; 159(1):196-203. PubMed ID: 19138730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum.
    Urenjak J; Obrenovitch TP
    J Neurochem; 2000 Dec; 75(6):2427-33. PubMed ID: 11080194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A; Takahashi K; Nishikawa T
    Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
    Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
    Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.